# Collegium Pharmaceutical, Inc – FDA Inspection, Mar 15, 2019

Source: https://www.keypedia.com/records/fda_inspections/collegium-pharmaceutical-inc/208d9a09-b4aa-455a-a4c1-a9c9e5b8aff0
Source feed: FDA_Inspections

> FDA inspection 1085723 of Collegium Pharmaceutical, Inc, March 15, 2019. Classification: No Action Indicated (NAI). 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1085723
- Company Name: Collegium Pharmaceutical, Inc
- Inspection Date: 2019-03-15
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 679887 - 2010-08-31
- FDA Inspection 546655 - 2008-10-23

## Related Officers

- [Company Rep](https://www.keypedia.com/people/victoria-m-daddeo/f1832c5e-d242-4e1a-8c30-4c951c3976ea)

Company: https://www.keypedia.com/companies/collegium-pharmaceutical-inc/4b463c1e-27ef-417a-949c-588341578889

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c